Global Rheumatology Therapeutics Market Outlook, 2030

2024

Global Rheumatology Therapeutics Market Outlook, 2030

Name: Global Rheumatology Therapeutics Market Outlook, 2030
Brand: Bonafide Research
SKU: 95002129
Price: 3450 USD
Availability: InStock
Rating: 5 (14.7 reviews)

Rheumatology Therapeutics market size was valued at US$ 45,350 million in 2023, reflecting increased demand for treatments targeting autoimmune and inflammatory conditions.

Bonafide Trust
04-09-2024
Pages : 102
Figures : 79
Tables : 103
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global rheumatology therapeutics market is experiencing substantial growth, largely fueled by the rising global incidence of chronic autoimmune and inflammatory diseases that primarily affect the joints, muscles, and connective tissues. These disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and systemic lupus erythematosus, are often progressive in nature and can result in long-term disability, reduced mobility, and significantly diminished quality of life for patients. The growing awareness among both patients and healthcare providers about the importance of early diagnosis, ongoing disease monitoring, and consistent treatment is contributing significantly to the expansion of the therapeutic landscape. Furthermore, an aging global population, which is more susceptible to musculoskeletal and autoimmune disorders due to the natural degeneration of tissues and weakened immune regulation, is increasing the overall patient pool. Advancements in medical science, particularly in immunology and molecular biology, have enabled the development of highly specific and effective medications that address the underlying mechanisms of these conditions rather than merely alleviating symptoms. As a result, the market is transitioning from traditional treatment modalities to more innovative approaches that emphasize long-term disease control, remission, and improved patient outcomes.

According to Publisher, the global Rheumatology Therapeutics market size was valued at US$ 45350 million in 2023. With growing demand in downstream market, the Rheumatology Therapeutics is forecast to a readjusted size of US$ 53070 million by 2030 with a CAGR of 2.3% during review period. Moreover, rapid technological advancements in drug development and delivery systems are shaping the evolution of rheumatology therapeutics, making treatments more precise, targeted, and effective. Pharmaceutical and biotechnology companies are increasing their investments in research and development initiatives to explore new treatment pathways, such as Janus kinase (JAK) inhibitors, interleukin blockers, and other novel biologics that offer superior efficacy in disease management. These agents have not only shown promise in reducing inflammation and slowing disease progression but have also provided patients with the opportunity to maintain a more active and productive lifestyle, thus improving their overall wellbeing. In parallel, biosimilars are being introduced to enhance treatment accessibility and affordability, especially in developing countries where the high cost of biologics remains a barrier to widespread use. The regulatory landscape is becoming increasingly favorable, with several health authorities around the world fast-tracking approvals for promising new therapies and expanding indications for existing medications. Additionally, collaboration between academia, research institutions, and pharmaceutical companies has facilitated the discovery of predictive biomarkers and individualized treatment plans, driving the push toward personalized medicine. As healthcare systems across different regions aim to provide better chronic disease management and long-term care, the demand for comprehensive and multidisciplinary rheumatology therapies is expected to grow steadily in the coming years.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

In terms of drug types, the rheumatology therapeutics market is broadly segmented into several major categories, each serving a unique function in the management of rheumatic and musculoskeletal diseases. These categories include disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, biologic agents, targeted synthetic drugs, and a variety of supportive treatments. Traditional DMARDs such as methotrexate, sulfasalazine, and hydroxychloroquine are often prescribed as first-line therapies due to their ability to suppress the immune system and delay the structural progression of diseases like rheumatoid arthritis. However, these conventional treatments have limitations, especially in patients who do not respond adequately or who develop adverse side effects. This has led to the growing adoption of biologic DMARDs, which include a range of targeted therapies such as TNF inhibitors (e.g., etanercept and adalimumab), interleukin inhibitors, and B-cell targeted therapies. These biologics have revolutionized the treatment paradigm by offering more specific action mechanisms, higher rates of clinical remission, and better quality of life for many patients. NSAIDs continue to play a crucial role in managing pain and inflammation, particularly during the early stages of disease or in conjunction with other therapies, although they are typically not sufficient for controlling disease progression. Corticosteroids remain widely used for their potent anti-inflammatory effects, especially during acute flare-ups, though their long-term use is often limited due to side effects such as osteoporosis, hypertension, and increased risk of infection. The emergence of oral targeted synthetic DMARDs, like JAK inhibitors, has added a convenient and effective option for patients, especially those who prefer or require non-injectable therapies. These innovations and the expanding portfolio of therapeutic types reflect a strategic shift toward personalized and adaptive treatment models, addressing the diverse and changing needs of patients throughout the course of their disease.

Segmentation of the rheumatology therapeutics market by application provides deeper insight into how various treatments are tailored to address specific disease conditions, each with its own clinical challenges, epidemiological patterns, and therapeutic needs. Among the most dominant applications is the treatment of rheumatoid arthritis, a systemic autoimmune disease that affects millions of people worldwide and is characterized by chronic joint inflammation, swelling, and irreversible joint damage if left untreated. This condition continues to drive the largest share of therapeutic development and sales, owing to its high prevalence and complex pathophysiology. Psoriatic arthritis, a comorbid condition associated with psoriasis, is another key application area, with treatment strategies designed to manage both dermatological symptoms and joint inflammation simultaneously. Ankylosing spondylitis, primarily affecting the axial skeleton and spine, has seen growing therapeutic attention with the introduction of biologics that specifically target inflammatory pathways unique to this condition. In addition to these major applications, the market includes therapies for other chronic conditions such as systemic lupus erythematosus, gout, juvenile idiopathic arthritis, osteoarthritis, and vasculitis syndromes. Each of these disorders requires specialized management approaches, influencing drug selection and treatment duration. Increasing clinical research has demonstrated that many biologic and targeted synthetic agents have efficacy across multiple indications, encouraging regulatory agencies and pharmaceutical companies to pursue label expansions and cross-indication approvals. This cross-applicability is streamlining treatment protocols and offering patients broader access to cutting-edge therapies. Moreover, with rising patient awareness and improved diagnostic capabilities, early detection of rheumatic diseases is becoming more common, enabling timely intervention and better prognoses. All of these factors contribute to the deepening segmentation of the market by application, underscoring the growing complexity and customization of therapeutic approaches in modern rheumatologic care.

Considered in this report

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

• Historic Year: 2019

• Base Year: 2024

• Estimated Year: 2025

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

• Forecast Year: 2030

Aspects covered in this report

• Global Rheumatology Therapeutics Market with its value and forecast along with its segments

• Various drivers and challenges

• Ongoing trends and developments

• Top profiled companies

• Strategic recommendations

By Drug Class:

• Disease Modifying Anti-Rheumatic Drugs (DMARDs)

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

• Corticosteroids

• Uric Acid Drugs

• Others

By Disease Indication:

• Rheumatoid Arthritis

• Osteoarthritis

• Gout

• Psoriatic Arthritis

• Ankylosing Spondylitis

• Others

By Distribution Channel:

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

The approach of the report:

This report employs a combined approach of primary and secondary research. Initially, secondary research was conducted to understand the market landscape and identify existing companies. Sources include press releases, annual reports, and government publications. Following this, primary research was carried out through telephonic interviews with key industry players to gain insights into market dynamics. Additionally, discussions were held with dealers and distributors. Consumer feedback was gathered through surveys, segmenting participants by region, age group, and purchasing behavior. The data obtained from primary research was then cross-verified with secondary sources for accuracy.

Intended audience

This report is valuable for industry consultants, manufacturers, suppliers, associations & organizations related to the rheumatology therapeutics industry, government bodies, and other stakeholders to align their market-centric strategies. Beyond marketing and presentations, it enhances competitive knowledge about the industry.

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rheumatology Therapeutics Market Size 2019-2030
2.1.2 Rheumatology Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Rheumatology Therapeutics Segment by Type
2.2.1 Disease Modifying Anti-rheumatic Drugs
2.2.2 Nonsteroidal Anti-inflammatory Drugs
2.2.3 Corticosteroids
2.2.4 Uric Acid Drugs
2.2.5 Others
2.3 Rheumatology Therapeutics Market Size by Type
2.3.1 Rheumatology Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Rheumatology Therapeutics Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Rheumatology Therapeutics Market Size by Application
2.5.1 Rheumatology Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
3 Rheumatology Therapeutics Market Size by Player
3.1 Rheumatology Therapeutics Market Size Market Share by Players
3.1.1 Global Rheumatology Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Rheumatology Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Rheumatology Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rheumatology Therapeutics by Regions
4.1 Rheumatology Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Rheumatology Therapeutics Market Size Growth (2019-2024)
4.3 APAC Rheumatology Therapeutics Market Size Growth (2019-2024)
4.4 Europe Rheumatology Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Rheumatology Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Rheumatology Therapeutics Market Size by Country (2019-2024)
5.2 Americas Rheumatology Therapeutics Market Size by Type (2019-2024)
5.3 Americas Rheumatology Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rheumatology Therapeutics Market Size by Region (2019-2024)
6.2 APAC Rheumatology Therapeutics Market Size by Type (2019-2024)
6.3 APAC Rheumatology Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rheumatology Therapeutics by Country (2019-2024)
7.2 Europe Rheumatology Therapeutics Market Size by Type (2019-2024)
7.3 Europe Rheumatology Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rheumatology Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Rheumatology Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Rheumatology Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rheumatology Therapeutics Market Forecast
10.1 Global Rheumatology Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Rheumatology Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Rheumatology Therapeutics Forecast
10.1.3 APAC Rheumatology Therapeutics Forecast
10.1.4 Europe Rheumatology Therapeutics Forecast
10.1.5 Middle East & Africa Rheumatology Therapeutics Forecast
10.2 Americas Rheumatology Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Rheumatology Therapeutics Market Forecast
10.2.2 Canada Rheumatology Therapeutics Market Forecast
10.2.3 Mexico Rheumatology Therapeutics Market Forecast
10.2.4 Brazil Rheumatology Therapeutics Market Forecast
10.3 APAC Rheumatology Therapeutics Forecast by Region (2025-2030)
10.3.1 China Rheumatology Therapeutics Market Forecast
10.3.2 Japan Rheumatology Therapeutics Market Forecast
10.3.3 Korea Rheumatology Therapeutics Market Forecast
10.3.4 Southeast Asia Rheumatology Therapeutics Market Forecast
10.3.5 India Rheumatology Therapeutics Market Forecast
10.3.6 Australia Rheumatology Therapeutics Market Forecast
10.4 Europe Rheumatology Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Rheumatology Therapeutics Market Forecast
10.4.2 France Rheumatology Therapeutics Market Forecast
10.4.3 UK Rheumatology Therapeutics Market Forecast
10.4.4 Italy Rheumatology Therapeutics Market Forecast
10.4.5 Russia Rheumatology Therapeutics Market Forecast
10.5 Middle East & Africa Rheumatology Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Rheumatology Therapeutics Market Forecast
10.5.2 South Africa Rheumatology Therapeutics Market Forecast
10.5.3 Israel Rheumatology Therapeutics Market Forecast
10.5.4 Turkey Rheumatology Therapeutics Market Forecast
10.5.5 GCC Countries Rheumatology Therapeutics Market Forecast
10.6 Global Rheumatology Therapeutics Forecast by Type (2025-2030)
10.7 Global Rheumatology Therapeutics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Information
11.1.2 Takeda Pharmaceutical Rheumatology Therapeutics Product Offered
11.1.3 Takeda Pharmaceutical Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Takeda Pharmaceutical Main Business Overview
11.1.5 Takeda Pharmaceutical Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Rheumatology Therapeutics Product Offered
11.2.3 Sanofi Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Genentech
11.3.1 Genentech Company Information
11.3.2 Genentech Rheumatology Therapeutics Product Offered
11.3.3 Genentech Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Genentech Main Business Overview
11.3.5 Genentech Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Rheumatology Therapeutics Product Offered
11.4.3 Novartis Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Information
11.5.2 Janssen Biotech Rheumatology Therapeutics Product Offered
11.5.3 Janssen Biotech Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Janssen Biotech Main Business Overview
11.5.5 Janssen Biotech Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Rheumatology Therapeutics Product Offered
11.6.3 Amgen Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Rheumatology Therapeutics Product Offered
11.7.3 AbbVie Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AbbVie Main Business Overview
11.7.5 AbbVie Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Rheumatology Therapeutics Product Offered
11.8.3 Pfizer Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Information
11.9.2 Bristol-Myers Squibb Company Rheumatology Therapeutics Product Offered
11.9.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bristol-Myers Squibb Company Main Business Overview
11.9.5 Bristol-Myers Squibb Company Latest Developments
11.10 Merck & Co.
11.10.1 Merck & Co. Company Information
11.10.2 Merck & Co. Rheumatology Therapeutics Product Offered
11.10.3 Merck & Co. Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Merck & Co. Main Business Overview
11.10.5 Merck & Co. Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Rheumatology Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Disease Modifying Anti-rheumatic Drugs
Table 3. Major Players of Nonsteroidal Anti-inflammatory Drugs
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Uric Acid Drugs
Table 6. Major Players of Others
Table 7. Rheumatology Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Table 10. Rheumatology Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Table 13. Global Rheumatology Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Rheumatology Therapeutics Revenue Market Share by Player (2019-2024)
Table 15. Rheumatology Therapeutics Key Players Head office and Products Offered
Table 16. Rheumatology Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Rheumatology Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Rheumatology Therapeutics Market Size Market Share by Regions (2019-2024)
Table 21. Global Rheumatology Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Rheumatology Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Rheumatology Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Rheumatology Therapeutics Market Size Market Share by Country (2019-2024)
Table 25. Americas Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Table 27. Americas Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Table 29. APAC Rheumatology Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Rheumatology Therapeutics Market Size Market Share by Region (2019-2024)
Table 31. APAC Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Table 33. APAC Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Table 35. Europe Rheumatology Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Rheumatology Therapeutics Market Size Market Share by Country (2019-2024)
Table 37. Europe Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Table 39. Europe Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Rheumatology Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Rheumatology Therapeutics
Table 48. Key Market Challenges & Risks of Rheumatology Therapeutics
Table 49. Key Industry Trends of Rheumatology Therapeutics
Table 50. Global Rheumatology Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Rheumatology Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Rheumatology Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Rheumatology Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Takeda Pharmaceutical Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 55. Takeda Pharmaceutical Rheumatology Therapeutics Product Offered
Table 56. Takeda Pharmaceutical Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Takeda Pharmaceutical Main Business
Table 58. Takeda Pharmaceutical Latest Developments
Table 59. Sanofi Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 60. Sanofi Rheumatology Therapeutics Product Offered
Table 61. Sanofi Main Business
Table 62. Sanofi Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Sanofi Latest Developments
Table 64. Genentech Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 65. Genentech Rheumatology Therapeutics Product Offered
Table 66. Genentech Main Business
Table 67. Genentech Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Genentech Latest Developments
Table 69. Novartis Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 70. Novartis Rheumatology Therapeutics Product Offered
Table 71. Novartis Main Business
Table 72. Novartis Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Novartis Latest Developments
Table 74. Janssen Biotech Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 75. Janssen Biotech Rheumatology Therapeutics Product Offered
Table 76. Janssen Biotech Main Business
Table 77. Janssen Biotech Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Janssen Biotech Latest Developments
Table 79. Amgen Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 80. Amgen Rheumatology Therapeutics Product Offered
Table 81. Amgen Main Business
Table 82. Amgen Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Amgen Latest Developments
Table 84. AbbVie Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 85. AbbVie Rheumatology Therapeutics Product Offered
Table 86. AbbVie Main Business
Table 87. AbbVie Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. AbbVie Latest Developments
Table 89. Pfizer Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 90. Pfizer Rheumatology Therapeutics Product Offered
Table 91. Pfizer Main Business
Table 92. Pfizer Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Pfizer Latest Developments
Table 94. Bristol-Myers Squibb Company Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 95. Bristol-Myers Squibb Company Rheumatology Therapeutics Product Offered
Table 96. Bristol-Myers Squibb Company Main Business
Table 97. Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Bristol-Myers Squibb Company Latest Developments
Table 99. Merck & Co. Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
Table 100. Merck & Co. Rheumatology Therapeutics Product Offered
Table 101. Merck & Co. Main Business
Table 102. Merck & Co. Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Merck & Co. Latest Developments

List of Figures
Figure 1. Rheumatology Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rheumatology Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Rheumatology Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Rheumatology Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Rheumatology Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Rheumatology Therapeutics Market Size Market Share by Type in 2023
Figure 10. Rheumatology Therapeutics in Hospital Pharmacy
Figure 11. Global Rheumatology Therapeutics Market: Hospital Pharmacy (2019-2024) & ($ Millions)
Figure 12. Rheumatology Therapeutics in Retail Pharmacy
Figure 13. Global Rheumatology Therapeutics Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 14. Rheumatology Therapeutics in Online Pharmacy
Figure 15. Global Rheumatology Therapeutics Market: Online Pharmacy (2019-2024) & ($ Millions)
Figure 16. Global Rheumatology Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Rheumatology Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Rheumatology Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Rheumatology Therapeutics Value Market Share by Country in 2023
Figure 24. United States Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Rheumatology Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Rheumatology Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Rheumatology Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Rheumatology Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Rheumatology Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Rheumatology Therapeutics Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted